EN 
Українська
Polski
Español
Deutsch
日本語
Italiano
Português (BR)
Français
العربية
Nederlands
中文
한국어
हिन्दी
Türkçe
Tiếng Việt
Русский
Bahasa Indonesia
فارسی
বাংলা
ไทย
Filipino
Kiswahili
اردو
Bahasa Melayu
தமிழ்
עברית
Ελληνικά
ਪੰਜਾਬੀ
አማርኛ
မြန်မာဘာသာ
ខ្មែរ
ქართული
नेपाली
Монгол хэл
Հայերեն
සිංහල
ລາວ
Čeština
Română
Magyar
Български
Svenska
Dansk
Suomi
Norsk
Slovenčina
Hrvatski
Српски
Slovenščina
Lietuvių
Latviešu
Eesti
Íslenska
Shqip
Македонски
Bosanski
Malti
Azərbaycanca
Қазақша
O'zbekcha
Тоҷикӣ
КыргызчаWhat SSRI/MAOI Interactions Are
Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of antidepressants that work by increasing the levels of serotonin in the brain. Monoamine Oxidase Inhibitors (MAOIs), on the other hand, prevent the breakdown of several neurotransmitters including serotonin and norepinephrine. When combined with psychedelic substances, these medications can lead to unpredictable effects and potential side effects.
Psychedelic drugs such as psilocybin or LSD alter brain chemistry by binding to specific receptors, particularly those for serotonin. The interaction between these substances and SSRIs/MAOIs can disrupt the normal functioning of neurotransmitters, leading to adverse outcomes.
Why It Matters
Understanding SSRI/MAOI interactions is crucial in psychedelic therapy settings as it helps prevent serious complications. For instance, MAOIs can potentiate the effects of psychedelics, potentially leading to hypertensive crises or serotonin syndrome if not properly managed.
Additionally, these interactions can affect the therapeutic outcomes and safety profiles of both the psychedelic substances and psychiatric medications.
Real-World Examples
For example, combining a psychedelic substance like psilocybin with an MAOI could lead to dangerously high blood pressure due to the inhibition of monoamine oxidase. Similarly, SSRIs can reduce the effectiveness of psychedelics by altering their metabolism and distribution in the body.
In clinical settings, it is essential for healthcare providers to screen patients taking SSRIs or MAOIs before administering any psychedelic substance.
FAQ
Who should avoid using psychedelic substances if they are on SSRIs or MAOIs?
Individuals taking SSRIs or MAOIs should consult their healthcare provider and avoid using psychedelic substances to prevent potential interactions that could lead to serious health issues. Both classes of medications can significantly alter the effects of psychedelics, posing risks such as serotonin syndrome or hypertensive crises.
Frequently asked questions
Can SSRIs and MAOIs be taken together?
No, SSRIs and MAOIs should not be combined because they can lead to dangerous side effects. The combination of these medications can cause a buildup of serotonin in the brain, leading to conditions like serotonin syndrome.
What are the signs of serotonin syndrome?
Serotonin syndrome symptoms include agitation, muscle rigidity, fever, rapid heart rate, and changes in mental status. It is important to seek medical attention immediately if these symptoms occur after taking a psychedelic substance with SSRIs or MAOIs.
How can one safely use psychedelics without risking interactions?
To avoid interactions, individuals should inform their healthcare providers about all medications they are taking and follow professional advice. This includes temporarily discontinuing certain medications under medical supervision before using psychedelic substances.
Are there any specific psychedelic substances that pose a higher risk with SSRIs or MAOIs?
Psilocybin, MDMA, and DMT are among the psychedelic substances known to have significant interactions with SSRIs and MAOIs. It is particularly important for individuals taking these medications to be cautious.
Try it live
Everything above runs in your browser — open Psychedelic-Drug Interaction Screening (SSRI/MAOI) Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open Psychedelic-Drug Interaction Screening (SSRI/MAOI) Simulator simulation